hero-orange

Platform & Pipeline

Platform

Our platform consists of three fundamental elements:

Group-230-fix

14-3-3 Encyclopedia

The 14-3-3 encyclopedia provides a systematic understanding of the 14-3-3:client interface so that we can achieve predictive, efficient structure-chemotype pairing in a modular fashion, substantially streamlining the drug discovery process. With an extensive client database of binding motifs and 14-3-3:client protein structures, we can more quickly identify the most promising candidates from our library of privileged scaffolds to begin the screening process.

Pipeline

Our pipeline focuses on neurodegeneration and oncology where multiple opportunities exist to engage currently undrugged targets and where a 14-3-3 molecular glue strategy is clearly differentiated from existing approaches.

*Michael J. Fox Foundation (MJFF) funded consortium; collaboration with academic experts
**Exploratory program; collaboration with academic experts

Target class
Target Activity
Stage
Target Competition
Therapeutic Area
BIC / FIC potential
* Kinase
Regulator of endolysosomal processes
and vesicular trafficking
Lead optimization
Clinical
Neurodegeneration
BIC
Lead optimization
Transcription factor & Structural protein
Regulator of tissue homeostasis and adhesion
Hit exploration
Clinical
Oncology
BIC
Hit exploration
** Transcription factor
Master regulator of glucose and fat metabolism
Hit-to-lead
Undrugged
Metabolic
FIC
Hit-to-lead
** Structural protein
Promotes microtubule assembly and stability
Hit exploration
Clinical
Neurodegeneration
FIC
Hit exploration
** Structural protein
Vesicle trafficking,
neurotransmitter release
Target validation
Clinical
Neurodegeneration
BIC
Target validation